Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
일본 COVID-19 환자에서 항 SARS-CoV-2 항체의 혈청 유병률
Clinical Trial
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Analysis
anti-SARS-CoV-2 antibody
anti-SARS-CoV-2 IgG
anti-SARS-CoV-2 IgG antibodies
anti-SARS-CoV-2 IgG antibody
antibody
clinical manifestation
clinical manifestations
CMIA
collected
complement
coronavirus
COVID-19
COVID-19 outpatient
COVID-19 outpatients
COVID-19 patient
COVID-19 patients
Critical
Critical case
critical cases
detection rate
determine
determined by
diagnosing
examined
IgG
IgG antibodies
IgG antibody
IgM
IgM antibodies
IgM antibody
IgM/IgG
immunoassay
immunochromatographic
Inpatient
Japanese
Microparticle
Mild
Mild symptom
mild symptoms
objective
PCR
positive
Rapid
Rapid test
respiratory
Result
SARS-CoV-2
SARS-CoV-2 IgG
Seroprevalence
serum sample
serum samples
severe acute respiratory syndrome Coronavirus
severe and critical cases
symptom onset
symptomatic
Test
titers
titers of IgG
[DOI] 10.1371/journal.pone.0249449 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1371/journal.pone.0249449 PMC 바로가기 [Article Type] Clinical Trial